169. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial.
作者: Timothy S Walsh.;Richard A Parker.;Leanne M Aitken.;Cathrine A McKenzie.;Lydia Emerson.;Julia Boyd.;Alix Macdonald.;Gayle Beveridge.;Annabel Giddings.;David Hope.;Sîan Irvine.;Sharon Tuck.;Nazir I Lone.;Kalliopi Kydonaki.;John Norrie.;David Brealey.;David Antcliffe.;Michael Reay.;Alan Williams.;Jeremy Bewley.;Benedict Creagh-Brown.;Daniel F McAuley.;Paul Dark.;Matt P Wise.;Anthony C Gordon.;Gavin D Perkins.;Michael C Reade.;Bronagh Blackwood.;Alasdair MacLullich.;Robert Glen.;Valerie J Page.;Christopher J Weir.; .
来源: JAMA. 2025年
Whether α2-adrenergic receptor agonist-based sedation, compared with propofol-based sedation, reduces time to extubation in patients receiving mechanical ventilation in the intensive care unit (ICU) is uncertain.
173. Immune Thrombotic Thrombocytopenic Purpura: A Review.
Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy that presents with microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. Worldwide annual incidence of iTTP is 2 cases per million to 6 cases per million.
174. A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.
作者: .;Surya P Bhatt.;Ehsan Abadi.;Antonio Anzueto.;Sandeep Bodduluri.;Richard Casaburi.;Peter J Castaldi.;Michael H Cho.;Alejandro P Comellas.;Douglas J Conrad.;Jeffrey L Curtis.;Chandra Dass.;Dawn L DeMeo.;Mark T Dransfield.;Raul San José Estépar.;Eric L Flenaugh.;Marilyn G Foreman.;Spyridon Fortis.;Arnav Gupta.;MeiLan K Han.;Nicola A Hanania.;Craig P Hersh.;John E Hokanson.;Stephen M Humphries.;Miranda Kirby.;Ken M Kunisaki.;Pei Zhi Li.;David A Lynch.;Neil R MacIntyre.;Barry J Make.;David M Mannino.;Fernando J Martinez.;Charlene E McEvoy.;Bruce E Miller.;Matthew Moll.;Arie Nakhmani.;John D Newell.;Katherine A Pratte.;Elizabeth A Regan.;Joseph M Reinhardt.;Stephen I Rennard.;Harry B Rossiter.;Matthew J Strand.;Rajat Suri.;Emily S Wan.;Christine H Wendt.;Gloria E Westney.;Carla G Wilson.;Robert A Wise.;Kendra A Young.;Wan C Tan.;Edwin K Silverman.;James D Crapo.
来源: JAMA. 2025年333卷24期2164-2175页
Individuals at risk for chronic obstructive pulmonary disease (COPD) but without spirometric airflow obstruction can have respiratory symptoms and structural lung disease on chest computed tomography. Current guidelines recommend COPD diagnostic schemas that do not incorporate imaging abnormalities.
|